Skip to main content
      RT @drdavidliew: So how do we treat this long COVID thing?

      Some sensible hints here, but sadly I can't really say that

      David Liew drdavidliew

      3 years 2 months ago
      So how do we treat this long COVID thing? Some sensible hints here, but sadly I can't really say that we've got this under control. I feel helpless with the long COVID patients I've cared for. #ACR21 8M406 @RheumNow @galbamd @CCalabreseDO @philipcrobinson https://t.co/Vaw0QlUx50
      RT @drdavidliew: Given the choice, you want me to risk long COVID?
      No thanks. #GetVaccinated

      #ACR21 8M406 @RheumNow @ga

      David Liew drdavidliew

      3 years 2 months ago
      Given the choice, you want me to risk long COVID? No thanks. #GetVaccinated #ACR21 8M406 @RheumNow @galbamd @CCalabreseDO @philipcrobinson https://t.co/TCao34vWK8
      RT @MeralElRamahiMD: This is priceless:
      “Learning from our patients is a key highlight of #ACR21.” — Dr. S. Bhana

      Meral K. El Ramahi, MD MeralElRamahiMD

      3 years 2 months ago
      This is priceless: “Learning from our patients is a key highlight of #ACR21.” — Dr. S. Bhana I could not agree more: a patient’s insight is invaluable, irreplaceable, and essential. @RheumNow https://t.co/kS0NWVIpiG
      RT @MeralElRamahiMD: Knowledge Bowl at #ACR21

      ⭐️AMBITION trial data suggested combination of these meds might be mo

      Meral K. El Ramahi, MD MeralElRamahiMD

      3 years 2 months ago
      Knowledge Bowl at #ACR21 ⭐️AMBITION trial data suggested combination of these meds might be more effective than either alone in patients with pulmonary arterial HTN. ➡️Ambrisentan + tadalafil @RheumNow
      RT @MeralElRamahiMD: Knowledge Bowl at #ACR21

      ⭐️This type of vasculitis is most likely to cause proptosis

      ➡️G

      Meral K. El Ramahi, MD MeralElRamahiMD

      3 years 2 months ago
      Knowledge Bowl at #ACR21 ⭐️This type of vasculitis is most likely to cause proptosis ➡️GPA @RheumNow
      RT @MeralElRamahiMD: Knowledge Bowl at #ACR21

      ⭐️This protean tumefactive disease can rarely present with orbital my

      Meral K. El Ramahi, MD MeralElRamahiMD

      3 years 2 months ago
      Knowledge Bowl at #ACR21 ⭐️This protean tumefactive disease can rarely present with orbital myositis. ➡️IgG4-related Disease @RheumNow
      RT @MeralElRamahiMD: Knowledge Bowl at #ACR21

      ⭐️This is the most common chest imaging finding in a patient with rel

      Meral K. El Ramahi, MD MeralElRamahiMD

      3 years 2 months ago
      Knowledge Bowl at #ACR21 ⭐️This is the most common chest imaging finding in a patient with relapsing chondritis ➡️ Tracheal Stenosis @RheumNow
      RT @KDAO2011: Dr. K Costenbader #ACR21 #YearinReview will cover important studies for #ClinicalPractice:
      👉add on The

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Dr. K Costenbader #ACR21 #YearinReview will cover important studies for #ClinicalPractice: 👉add on Therapies 👉 the JAK evolution 👉improving clinical care 👉disparities in care @RheumNow https://t.co/dp1oeYMh8n
      RT @KDAO2011: 👉Voclosporin for SLE: rapid control of proteinuria (50% reduction over 29 days in UPCR w/o high side ef

      TheDaoIndex KDAO2011

      3 years 2 months ago
      👉Voclosporin for SLE: rapid control of proteinuria (50% reduction over 29 days in UPCR w/o high side effects) @rheumnow #YearInReview #ACR21 Are you all starting to use this drug now? It has helped my patients; pretty well tolerated. https://t.co/zqJRsjnV4n
      RT @KDAO2011: Dr. K Costenbader #ACR21 #YearinReview add-ons Rx:
      👉Avacopan for AAV: new oral C5a inh allowed for remi

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Dr. K Costenbader #ACR21 #YearinReview add-ons Rx: 👉Avacopan for AAV: new oral C5a inh allowed for remission & prevention of relapse, aggressive pred taper https://t.co/39V3LLOYKZ
      RT @KDAO2011: Experts (Drs. M Clowse, Sammaratino) limit mAb TNFi 1 month b/f delivery or extend dosing. But, they do do

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Experts (Drs. M Clowse, Sammaratino) limit mAb TNFi 1 month b/f delivery or extend dosing. But, they do dose again for flares. Risk for infection is low based on the PIANO registry. Postpartum, they restart the meds w/in 1 week (vag delivery), 2 weeks C/S @rheumnow #pregnancy
      RT @KDAO2011: Which of the following would you d/c in the 3rd trimester of pregnancy? #ACR21 #Pregnancy @rheumnow

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Which of the following would you d/c in the 3rd trimester of pregnancy? #ACR21 #Pregnancy @rheumnow
      RT @KDAO2011: Dr. M Clowse (on HCQ during pregnancy):
      👉All pregnant women get HCQ 400 mg/day regardless of how big t

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Dr. M Clowse (on HCQ during pregnancy): 👉All pregnant women get HCQ 400 mg/day regardless of how big they are (she does not dose based on mg/kg/d) 👉with maternal metabolism/volume distrib, levels are low. #ACR21 @rheumnow #pregnancy @drbags71 https://t.co/dZtFLdKOvk
      RT @KDAO2011: Is holding MTX during breastfeeding overblown?

      @MotherToBaby data showed that infants get 0.4% of mom’

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Is holding MTX during breastfeeding overblown? @MotherToBaby data showed that infants get 0.4% of mom’s dose 24 hrs post-MTX dose. Skip breastfeeding 1 day post-MTX may be safe. Consider monitoring infant CBC. Studies needed to follow infants longitudinally #ACR21 @rheumnow https://t.co/ikJvkk5BjI
      RT @KDAO2011: Dr. Chambers review @MotherToBaby prospective data on HCQ use in pregnancy (n=279):
      👉no major defects (

      TheDaoIndex KDAO2011

      3 years 2 months ago
      Dr. Chambers review @MotherToBaby prospective data on HCQ use in pregnancy (n=279): 👉no major defects (regardless of dose) 👉no oral clefts 👉SGA slightly lower in exposed group b/c of underlying dz 👉no case of retinopathy in babies after 1 year f/u @rheumnow #Pregnancy https://t.co/vw2eryFgro
      ×